Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Bladder Cancer Using Novel Tumor Antigens for Prevention of the Recurrence for Bladder Cancer After TUR-Bt

NCT00633204 is registered in ClinicalTrials.gov with Iwate Medical University as lead sponsor.

NCT NCT00633204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00633204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Bladder Cancer Using Novel Tumor Antigens for Prevention of the Recurrence for Bladder Cancer After TUR-Bt
Lead sponsor
Iwate Medical University
Phase
Phase 2
Overall status
Unknown status
Start date
February 29, 2008
Completion date
November 30, 2011
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer